Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 5/23/05 → 1/31/13 |
Financiación
- Acambis Inc: 15.261,00 US$
A Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study of the Safety, Tolerability and Immunogenicity of a Clostridium difficile Toxoid Vaccine, Alum Adsorbed, in Healthy Adult volunteers (18-55 years)
- Greenberg, Richard (PI)